期刊文献+

代谢综合征患者血浆chemerin水平变化及其相关因素 被引量:8

原文传递
导出
摘要 代谢综合征是主要由胰岛素抵抗引发的一系列生化、临床代谢异常,主要危险因素包括肥胖、糖尿病或糖耐量异常、血脂代谢紊乱、高血压和微量蛋白尿等,其实质是心脑血管疾病的多种代谢危险因素在个体内的聚集。随着全球肥胖患者日益增加,上述疾病呈集结状态发病情况不断增多。
出处 《中华糖尿病杂志》 CAS 2012年第6期370-372,共3页 CHINESE JOURNAL OF DIABETES MELLITUS
基金 江苏省自然科学基金(BK2009208) 镇江市社会发展项目(SH2008037) 江苏大学』临床医学科技发展基金(JLY20080003)
  • 相关文献

参考文献13

  • 1Eckle RH,Grundy SM,Zimmet PZ. The metabolic syndrome[J].The Lancet,2005.1415-1428.
  • 2Bozaoglu K,Bolton K,McMillan J. Chemerin is a novel adipokine associated with obesity and metabolic syndrome[J].Endocrinology,2007.4687-4694.
  • 3Ailhaud G. Adipose tissue as a secretory organ:from adipogenesis to the metabolic syndrome[J].Comptes Rendus Biologies,2006.570-577.
  • 4关亚群,赵学信,孙丽丽,张成,艾克拜尔.艾力,李惠武.维吾尔族代谢综合征患者chemerin的表达及相关因素[J].中华高血压杂志,2010,18(8):733-738. 被引量:8
  • 5宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:611
  • 6Wittamer V,Franssen JD,Vulcano M. Specific recruitment of antigen-presenting cells by chemerin,a novel processed ligand from human inflammatory fluids[J].Journal of Experimental Medicine,2003.977-985.
  • 7Goralski KB,Meearthy TC,Hanniman EA. Chemerin,a novel adipokine that regulates adipogenesis and adipocyte metabolism[J].Journal of Biological Chemistry,2007.28175-28188.
  • 8Takahashi M,Takahashi Y,Takahashi K. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes[J].FEBS Letters,2008.573-578.
  • 9Sell H,Laurencikiene J,Taube A. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells[J].Diabetes,2009.2731-2740.
  • 10丁晓东,范建高.肝脏胰岛素抵抗的机制和后果[J].中华糖尿病杂志,2009,1(4). 被引量:4

二级参考文献61

  • 1曾小云,谢自敬,伊力哈木.乌鲁木齐市维吾尔族成年人超重和肥胖的流行病学调查[J].中国临床康复,2005,9(3):17-19. 被引量:22
  • 2陈长春,王丽,牟小梅.新疆自治区喀什地区35岁以上维吾尔族人群超重和肥胖的现况调查[J].中华流行病学杂志,2005,26(2):119-119. 被引量:7
  • 3纪立农.国际糖尿病联盟代谢综合征全球共识定义解读[J].中华糖尿病杂志(1006-6187),2005,13(3):175-177. 被引量:88
  • 4Bozaoglu K, Bolton K, MeMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome[J]. Endocrinology, 2007,148(10) : 4687-4694.
  • 5Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ[JJ. Proc Nutr Soc,2001,60(3) :329-339.
  • 6Takahashi M, Takahashia Y, Takahashib K, et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3Ta-L1 adipoeytes[J]. FEBS Letters, 2008, 582 (5): 573-578.
  • 7Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance[J]. J Clin Invest, 2003,112 (8) : 1821-1830.
  • 8Mori Y, Hoshino K, Yokota K, et al. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men[J]. Exp Clin Endocrinol Diabetes,2005(6) :113- 113.
  • 9Ryo M, Nakamura T, Kihara S, etal. Adiponectin as a biomark er of the metabolic syndrome[J]. Circ J,2004,68(5) :975-981.
  • 10Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome[J]. Obes Res, 2004, 12(2) : 180-186.

共引文献620

同被引文献114

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部